A SOFTWARE CONTROLLED ACCESS CONTROL DOOR CONTROLLER
    71.
    发明申请
    A SOFTWARE CONTROLLED ACCESS CONTROL DOOR CONTROLLER 有权
    软件控制门禁控制器

    公开(公告)号:US20080094171A1

    公开(公告)日:2008-04-24

    申请号:US11574070

    申请日:2004-10-07

    CPC classification number: G07C9/00103

    Abstract: The present invention is an access control door controller which utilizes three relays, 16 alarm inputs, tamper switch, a Weigand reader, a RS 232 reader and a IP core module to enable access control alarm monitoring, inter locking of doors and/or energy management for a room with the help of a software. The present invention utilizes a distributed communication (peer to peer) thus creating a door access controller System network with a truly distributed intelligence permitting exchange of information between all controllers which may be situated in a single site or over multiple sites connected on a common network. The full system can be configured on the widely used TCP/IP network thus avoiding the need for extensive wiring traditionally required for Access Control System. The controller, with its associated software can support multiple types of readers and can directly interface IP cameras for an integrated TCP/IP based Access Control/CCTV Solution.

    Abstract translation: 本发明是一种访问控制门控制器,它使用三个继电器,16个报警输入,篡改开关,Weigand读取器,RS 232读取器和IP核心模块,以实现访问控制报警监控,门锁和/或能量管理 在一个软件的帮助下的房间。 本发明利用分布式通信(对等),从而创建具有真正分布式智能的门禁控制器系统网络,允许在可以位于单个站点中的多个站点之间的所有控制器之间交换信息,或者连接在公共网络上的多个站点之间交换信息。 可以在广泛使用的TCP / IP网络上配置完整的系统,从而避免了访问控制系统传统上需要的广泛布线。 控制器及其相关软件可以支持多种类型的读取器,并可以直接将IP摄像机接入基于TCP / IP的集成式访问控制/闭路电视解决方案。

    Wireless remote control for alternate current (A.C.) electrical lighting and appliances with learn function
    75.
    发明授权
    Wireless remote control for alternate current (A.C.) electrical lighting and appliances with learn function 失效
    无线遥控器用于交流电(A.C.)电气照明和具有学习功能的电器

    公开(公告)号:US06771182B1

    公开(公告)日:2004-08-03

    申请号:US09711657

    申请日:2000-11-13

    CPC classification number: H04B1/202 G08C23/04 G08C2201/20 G08C2201/92

    Abstract: A wireless remote and infrared receivers for controlling AC appliances connected to the receivers, capable of leaning codes from other infrared remotes. The system can control light intensity, has a 24-hour programmable daily timer, a selectable sleep timer, and switching for appliances connected to the receivers. The system has an energy saving interval timer for heating and fan ventilation, and a transmitter capable of learning and unifying remotes for other home equipment into one master remote. As a safety measure the receiver has a mechanical bypass switch. The receiver may decode an activation/deactivation sequence on the power line from the main switch connected to the receiver to self bypass. When bypassed, the main switch regains direct control of the appliances. Simultaneously, besides bypassing the receiver, within five seconds the user may have the receiver memorize any key from any other remote to take over control of the appliances.

    Abstract translation: 一种用于控制连接到接收器的AC设备的无线远程和红外接收器,能够倾斜来自其他红外遥控器的代码。 该系统可以控制光强度,具有24小时可编程的每日定时器,可选择的睡眠定时器以及连接到接收器的设备的切换。 该系统具有用于加热和风扇通风的节能间隔定时器,以及能够将其他家用设备的遥控器学习和统一为一个主遥控器的发射机。 作为安全措施,接收机具有机械旁路开关。 接收机可以解码来自连接到接收机的主交换机的电力线上的激活/去激活序列以自我旁路。 当旁路时,主开关重新获得对电器的直接控制。 同时,除了绕过接收机之外,用户可以在五秒钟之内使用任何其他遥控器来存储任何密钥以接管设备的控制。

    Glipizide-cyclodextrin inclusion complexes and their pharmaceutical composition
    76.
    发明授权
    Glipizide-cyclodextrin inclusion complexes and their pharmaceutical composition 失效
    格列吡嗪 - 环糊精包合物及其药物组成

    公开(公告)号:US06464988B1

    公开(公告)日:2002-10-15

    申请号:US09852141

    申请日:2001-05-09

    CPC classification number: B82Y5/00 A61K47/6951

    Abstract: Inclusion complexes of glipizide and a nonionic surfactant with cyclodextrin and cyclodextrin derivatives. A method of preparing the inclusion complexes of glipizide and a nonionic surfactant with cyclodextrin and cyclodextrin derivatives, by wetting cyclodextrin or a derivative thereof with a nonionic surfactant, and mixing the resulting mixture with glipizide. A pharmaceutical composition containing an inclusion complex of glipizide and a nonionic surfactant with cyclodextrin and cyclodextrin derivatives, in combination with pharmaceutically acceptable excipients.

    Abstract translation: 格列吡嗪和非离子表面活性剂与环糊精和环糊精衍生物的包合物。 通过用非离子表面活性剂润湿环糊精或其衍生物,并将所得混合物与格列吡嗪混合来制备格列吡嗪和非离子表面活性剂与环糊精和环糊精衍生物的包合物的方法。 含有格列吡嗪和非离子表面活性剂与环糊精和环糊精衍生物的包合物与药学上可接受的赋形剂组合的药物组合物。

    Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride
    77.
    发明授权
    Cyclodextrin stabilized pharmaceutical compositions of bupropion hydrochloride 失效
    环糊精稳定的盐酸安非他酮药物组合物

    公开(公告)号:US06462237B1

    公开(公告)日:2002-10-08

    申请号:US09881582

    申请日:2001-06-14

    Abstract: An inclusion complex of bupropion hydrochloride with beta cyclodextrin that stabilizes the bupropion hydrochloride against degradation. A method of preparing an inclusion complex of bupropion hydrochloride with beta cyclodextrin that stabilizes the bupropion hydrochloride against degradation. A novel stabilized sustained-release pharmaceutical composition of bupropion hydrochloride containing an inclusion complex of bupropion hydrochloride with beta cyclodextrin. A method of preparing a novel stabilized sustained-release pharmaceutical composition containing an inclusion complex of bupropion hydrochloride with beta cyclodextrin.

    Abstract translation: 盐酸安非他酮与β环糊精的包合物,使盐酸安非他酮稳定化,降解。 制备盐酸安非他酮与β-环糊精的包合物的方法,其使盐酸安非他酮稳定化以降解。 一种新颖的盐酸安非他酮缓释药物组合物,其含有盐酸安非他酮与β-环糊精的包合物。 一种制备含有盐酸安非他酮与β-环糊精的包合物的新型稳定缓释药物组合物的方法。

    Method for identifying UML objects in a repository with objects in XML content
    79.
    发明授权
    Method for identifying UML objects in a repository with objects in XML content 有权
    使用XML内容中的对象来识别存储库中的UML对象的方法

    公开(公告)号:US06408311B1

    公开(公告)日:2002-06-18

    申请号:US09345290

    申请日:1999-06-30

    CPC classification number: G06F8/24 Y10S707/99954

    Abstract: In a computer system executing a repository program and having a memory, a method is disclosed for identifying UML objects in the repository with objects in an XML file. The method includes the steps of parsing the XML file into XML objects and building an object tree. Next, the object tree is traversed a first time, and for each XML object found that has a name, corresponding UML objects are identified. After this, the object tree is traversed a second time, and for each XML object found that does not have a name, corresponding UML objects are then identified through Compositions and References. The method for traversing said object tree a first time includes the steps of identifying a UML object type for each XML object, and when the XML object name matches the UML object name at the current level, a UML and XML object IDs are saved in a ‘Conversion’ object in the memory.

    Abstract translation: 在执行存储库程序并具有存储器的计算机系统中,公开了一种用于使用XML文件中的对象来识别存储库中的UML对象的方法。 该方法包括将XML文件解析为XML对象和构建对象树的步骤。 接下来,第一次遍历对象树,并且对于发现具有名称的每个XML对象,都标识相应的UML对象。 之后,第二次遍历对象树,并且对于找不到名称的每个XML对象,然后通过“组合和参考”来标识相应的UML对象。 第一次遍历对象树的方法包括识别每个XML对象的UML对象类型的步骤,并且当XML对象名称与当前级别的UML对象名称相匹配时,将UML和XML对象ID保存在 内存中的“转换”对象。

    Sustained release pharmaceutical composition containing glipizide and method for producing same
    80.
    发明授权
    Sustained release pharmaceutical composition containing glipizide and method for producing same 失效
    含有格列吡嗪的缓释药物组合物及其制造方法

    公开(公告)号:US06270797B1

    公开(公告)日:2001-08-07

    申请号:US09573290

    申请日:2000-05-18

    CPC classification number: A61K31/64 A61K9/2054

    Abstract: One aspect of the invention resides in a monolithic sustained release composition of glipizide for patients with non-insulin dependent diabetes mellitus that exhibits a breakdown after ingestion by a patient in conformity with a zero-order kinetic. The present invention provides a composition of a glipizide and a hydrocolloid forming agent and optimally other auxiliary excipients for the sustained release of glipizide. It is preferable that the hydrophilic material comprises at least 50% by weight of the composition. The present invention is also directed to the process for producing the composition. One aspect of this process includes the steps of granulating glipizide, a hydrophilic material and a diluent, drying the granulated product and lubricating the product with a flow regulating agent and lubricant.

    Abstract translation: 本发明的一个方面在于用于患有非胰岛素依赖性糖尿病的患者的格列吡嗪的单片持续释放组合物,其在患者摄取后显示符合零级动力学的分解。 本发明提供了格列吡嗪和水胶体形成剂的组合物以及用于持续释放格列吡嗪的最佳其它辅助赋形剂。 优选亲水材料包含至少50重量%的组合物。 本发明还涉及组合物的制造方法。 该方法的一个方面包括将格列吡嗪,亲水性材料和稀释剂造粒,干燥造粒产物并用流动调节剂和润滑剂润滑产品的步骤。

Patent Agency Ranking